Jun Matsushima

Jun Matsushima

Auto-generated profile, based on publicly available information

Jun Matsushima

Department of Pathology, Saitama Medical Center, Dokkyo Medical University, Saitama, Japan

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 December 2017 in Oncotarget
Verified
Journal Article
Open access
PDF file
YYYoichi Yoshida
Yoichi Yoshida
HWHao Wang
Hao Wang
Takaki HiwasaTakaki Hiwasa
Takaki Hiwasa
TMToshio Machida
Toshio Machida
EKEiichi Kobayashi
Eiichi Kobayashi
YIYasuo Iwadate
Yasuo Iwadate
Background: Disease specific autoantibodies have been detected in the sera of patients with atherosclerosis-related diseases, such as cerebral infarction, cardiovascular disease. In the present study, we aimed to identify novel autoantibodies responsible for transient ischemic attack (TIA), a prodromal condition for cerebral infarction.

27 July 2022 in International Journal of Surgical Pathology
Verified
Journal Article
Closed access
JMJun Matsushima
Jun Matsushima
TSTamotsu Sato
Tamotsu Sato
TOTakashi Ohnishi
Takashi Ohnishi
YYYuichiro Yoshimura
Yuichiro Yoshimura
HMHiroyuki Mizutani
Hiroyuki Mizutani
HHHideki Hayashi
Hideki Hayashi
Objectives. The diversifying modalities of treatment for gastric cancer raise urgent demands for the rapid and precise diagnosis of metastases in regional lymph nodes, thereby significantly impact the workload of pathologists. Meanwhile, the recent advent of whole-slide scanners and deep-learning techniques have enabled the computer-assisted analysis of histopathological images, which could help to alleviate this impact. Thus, we developed a deep learning-based diagnostic algorithm to detect lymph node metastases of gastric adenocarcinoma and evaluated its performance. Methods. We randomly selected 20 patients with gastric adenocarcinoma who underwent surgery as definitive treatment and were found to be node metastasis-positive. HEMATOXYLIN-eosin (HE) stained glass slides, including a total of 51 metastasis-positive nodes, were retrieved from the specimens of these cases. Other slides with 776 metastasis-negative nodes were also retrieved from other twenty cases with the same disease that were diagnosed as metastasis-negative by the final pathological examinations. All glass slides were digitized using a whole-slide scanner. A deep-learning algorithm to detect metastases was developed using the data in which metastasis-positive parts of the images were annotated by a well-trained pathologist, and its performance in detecting metastases was evaluated. Results. Cross-validation analysis indicated an area of 0.9994 under the receiver operating characteristic curve. Free-response receiver operating characteristic curve (FROC) analysis indicated a sensitivity of 1.00 with three false positives. Further evaluation using an independent dataset also showed similar level of accuracies. Conclusion. This deep learning-based diagnosis-aid system is a promising tool that can assist pathologists involved in gastric cancer care and reduce their workload.

16 December 2021 in International Journal of Surgical Pathology
Verified
Journal Article
Closed access
PDF file
HIHiromichi Inoue
Hiromichi Inoue
JMJun Matsushima
Jun Matsushima
SKSatoru Kobayashi
Satoru Kobayashi
TSToshimi Sairenchi
Toshimi Sairenchi
HHHirokuni Hirata
Hirokuni Hirata
YMYuji Matsumura
Yuji Matsumura
Small cell lung carcinoma (SCLC) and pulmonary large cell neuroendocrine carcinoma (LCNEC) are both classified as lung neuroendocrine carcinoma (NEC). It has recently been reported that the special AT-rich sequence-binding protein 2 (STAB2), known as a colorectal cancer marker, is also expressed in NECs occurring in various organs including the lung. However, few studies have examined any differences of SATB2 immunopositivity between SCLC and LCNEC. We investigated SATB2 expression in 45 SCLC and 14 LCNEC cases using immunohistochemistry as well as the expression of caudal-type homeobox 2 (CDX2) and keratin (KRT) 20. The LCNEC cases were more frequently positive for SATB2 (ten out of 14, 71%) than the SCLC ones (seventeen out of 45, 38%) with a statistically significance (P = 0.035). Furthermore, two LCNEC cases were positive for CDX2 while no positive findings were observed for any SCLC cases, the difference of which, however, was not statistically significant (P = 0.053). KRT20 was negative in all LCNEC and SCLC cases. These results require our attention when we use SATB2 and CDX2 as colorectal cancer markers because their expression in pulmonary NECs can lead to a misdiagnosis that the tumor is of metastatic colorectal adenocarcinoma, especially when the patient has a past history of colorectal cancer. Analyzing the relationship between the demographic/clinical variables and the SATB2 expression in the SCLC cases, just high Brinkman index (≥ 600) was significantly related to the positivity of SATB2 (P = 0.017), which is interesting considering the strong relationship between SCLC and smoking.

1 January 2017 in The Bulletin of Tokyo Dental College
Verified
Journal Article
Open access
PDF file
MWMamoru Wakoh
Mamoru Wakoh
YSYoshinori Sasaki
Yoshinori Sasaki
MOMika Otonari-Yamamoto
Mika Otonari-Yamamoto
TGTazuko Goto
Tazuko Goto
SOSatoru Ogane
Satoru Ogane
YNYukio Nakatani
Yukio Nakatani
Kaposi's sarcoma (KS) is one of the most common diseases in patients with acquired immunodeficiency syndrome, but is rarely encountered in dental practice in Japan. We encountered a case of oral KS (OKS) presenting in the hard palate, gingiva, and tongue in a 41-year-old man. We report the results of imaging, including computed tomography (CT), magnetic resonance imaging, and positron emission tomography/CT in this case. The process leading to an imaging diagnosis of OKS is discussed, emphasizing the importance of collating clinical, laboratory, pathological, and radiological findings. The present results suggest that mapping of accurate tumors is very important in cases of OKS, and that multiple or bilateral manifestations, ill-defined margins, osteolysis, and swollen lymph nodes, in particular, need to be taken into account.

3 March 2021 in Human Pathology: Case Reports
Verified
Journal Article
Open access
TSTaiki Sato
Taiki Sato
YOYuko Ono
Yuko Ono
JMJun Matsushima
Jun Matsushima
AFAkiko Fujii
Akiko Fujii
YSYoko Sato
Yoko Sato
SBShinichi Ban
Shinichi Ban
TAFRO (Thrombocytopenia, Anasarca, Fever and/or elevated C-reactive protein, Renal dysfunction or Reticulin fibrosis, and Organomegaly) syndrome is a unique systemic inflammatory disease, which has recently been proposed from Japan. We report a case showing TAFRO symptoms, the patient’s condition of which allowed histopathological examinations of several biopsy tissues including the kidney. A 37-year-old man was admitted to our hospital for evaluation of fever of unknown origin, pleural effusion and ascites, renal dysfunction, and lymphadenopathy. Serum IL-6 and VEGF were elevated. Histopathologic findings of the lymph node resembled those of mixed type Castleman disease. The bone marrow biopsy specimen revealed normocellular marrow with a mildly increased number of megakaryocytes, but without obvious fibrosis. The renal biopsy material showed glomerular microangiopathy with double contour of the capillary loops and mesangiolysis. In immunohistochemistry, VEGF was retained in podocytes, whereas IL-6 expression was not limited to the specific sites. Glomerular microangiopathy is regarded as a crucial change in TAFRO syndrome, which should be studied further with regard to VEGF and IL-6.